Lv0
0 积分 2026-09-15 加入
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts-what truly defines the disease and does it matter?
11小时前
求助中
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
11小时前
已完结
Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS
11小时前
求助中
The conundrum of drug development in higher-risk MDS: lessons learned from recently failed phase 3 clinical trials
11小时前
已完结
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
12小时前
已完结
皖公网安备34019202002308
